Moneycontrol
HomeNewsBusinessIndia a very important market, believe bilaterals have to expand, says flydubai’s Ghaith Al Ghaith
Trending Topics

India a very important market, believe bilaterals have to expand, says flydubai’s Ghaith Al Ghaith

flydubai CEO Ghaith Al Ghaith also says that while the Indian aviation market presents a good opportunity, his company is currently focused on business in the emirate

November 25, 2021 / 13:50 IST
Story continues below Advertisement
Airplane Flydubai Boeing 737-800 at Dubai International Airport at sunset (Image: Shutterstock)

The Boeing 737 MAX on static display at the Dubai Airshow was turning out to be a big hit. Visitors to the show were lining up to view the business class section of the aircraft which offers lie-flat beds, something that is rare in a narrowbody aircraft like the MAX or the Airbus 320 family.

Seeing the crowds, Ghaith Al Ghaith, chief executive officer, flydubai, shifted to the economy class section of the aircraft for the interview. “As far as business is concerned we are going through a very difficult time now,” but “the Indian market being the largest provides huge potential as we move forward,” Al Ghaith said.

Story continues below Advertisement

While being clear that the government in his opinion “knows better”, Al Ghaith also hoped there would be more capacity than less (between the United Arab Emirates and India).

Al Ghaith started his career at UAE flag carrier Emirates in 1986 as a management trainee. During his more than 20-year-long career at Emirates, he held a number of positions including executive vice-president, commercial operations worldwide, and area manager, UK and Ireland. Here are the edited excerpts:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show